Landos Biopharma
Company · Blacksburg, United States
Clinical-stage biopharma developing oral NLRX1 agonist NX-13; formerly Nasdaq listed, now part of AbbVie.
Closed or ended, checked October 14, 2026.
In context
Landos Biopharma is one of 4 companies in Blacksburg, Virginia listed in the Innovative EcoSystems registry, and one of 898 across the United States.
The registry lists 63 innovation ecosystem organizations in Blacksburg, Virginia in all.
Companies active in the regional innovation ecosystem, as partners, customers, employers or investors.
The United States scores 68.5 out of 100 on the IEPA (2024 edition), ranking 21 of 117 economies.
See the United States on the IEPA ↗
More companies in Blacksburg, Virginia
- Ozmo
Blacksburg - Sentek Instrument
Blacksburg - Revivicor
Blacksburg
Elsewhere in Blacksburg, Virginia
- Techulon (United States)
Corporate R&D - Apex Systems Center for Innovation and Entrepreneurship
College or training provider - Virginia Agricultural Experiment Station
Government or public body - LewisGale Hospital Montgomery
Health research - Entrepreneur Resource Center (VTCRC)
Incubator - QCowork
Innovation hub - Virginia Tech Foundation
Investor or fund - Project Rise
Program
More companies in the United States
- Da Primus Consulting
Louisville - Kaufman Rossin
Boca Raton - Trafigura Trading
Houston - Aurora Organic Dairy
Platteville - Babylon Micro-Farms
Richmond - Celsius Holdings
Boca Raton - Intel Ohio One
New Albany - FINFROCK
Belle Glade